TY - JOUR
T1 - Fibronectin-fibrin cross-linking
T2 - A regulator of cell behavior
AU - Corbett, Siobhan A.
AU - Schwarzbauer, Jean E.
N1 - Funding Information:
This work was supported by the National Institutes of Health and the American Heart Association.
Copyright:
Copyright 2018 Elsevier B.V., All rights reserved.
PY - 1998/11
Y1 - 1998/11
N2 - At sites of tissue injury or inflammation, extravasation of plasma proteins leads to the formation of a complex fibrillar matrix composed primarily of fibrin and plasma fibronectin (pFN). This protein meshwork serves not only to reestablish the integrity of the vascular system but also to provide a scaffold for cell migration and subsequent wound repair. The interactions between cell surface receptors and this provisional extracellular matrix (ECM) provide important cues that can modulate the cellular response at the injury site, leading to alterations in cell growth and gene expression. Key determinants of this response may lie in the structure and composition of this 'injury-associated' ECM.
AB - At sites of tissue injury or inflammation, extravasation of plasma proteins leads to the formation of a complex fibrillar matrix composed primarily of fibrin and plasma fibronectin (pFN). This protein meshwork serves not only to reestablish the integrity of the vascular system but also to provide a scaffold for cell migration and subsequent wound repair. The interactions between cell surface receptors and this provisional extracellular matrix (ECM) provide important cues that can modulate the cellular response at the injury site, leading to alterations in cell growth and gene expression. Key determinants of this response may lie in the structure and composition of this 'injury-associated' ECM.
UR - http://www.scopus.com/inward/record.url?scp=0031677822&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0031677822&partnerID=8YFLogxK
U2 - 10.1016/S1050-1738(98)00028-0
DO - 10.1016/S1050-1738(98)00028-0
M3 - Article
C2 - 14987550
AN - SCOPUS:0031677822
SN - 1050-1738
VL - 8
SP - 357
EP - 362
JO - Trends in Cardiovascular Medicine
JF - Trends in Cardiovascular Medicine
IS - 8
ER -